JPRN-UMIN000000625已完成2 期
Randomized controlled phase II trial of gemcitabine/radiation combination therapy and gemcitabine monotherapy in locally advanced biliary tract cancer. - gemcitabine/radiation combination therapy and gemcitabine monotherapy in biliary tract cancer
First Dept. Internal Medicine Gifu University Hospital0 个研究点目标入组 60 人开始时间: 2007年3月3日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.Patients with interstitial pneumonia, pulmonary fibrosis. 2.Patients with intractable diabetes mellitus, liver dysfunction, angina pectoris, or myocardinal infarction within months after onset. 3.Patients with suspicious of serious infection, or serious infection. 4.Patients with pregnacy, during lactation, or patient with hope of pregnant 5.Patients with severe drug allergy 6.Patients with severe concomitant disease 7.Patients with pleural effusion or ascites 8.Patients with active multiple cancers 9.The patients judged inappropriate in enrolling into this study by the investigators
研究者
相似试验
已完成
2 期
Randomized controlled phase II trial of gemcitabine/radiation combination therapy and gemcitabine monotherapy in locally advanced pancreatic cancer.locally advanced unresectable pancreatic cancerJPRN-UMIN000000624First Dept. Internal Medicine Gifu University Hospital60
未知
2 期
Randomized phase II trial of gemcitabine(GEM) and carboplatin (CBDCA) with or without Dexamethasone(Dex) in untreated non-small cell lung cancer (NSCLC).on small cell lung cancerJPRN-UMIN000000547Kyoto Thoracic Oncology Research Group (KTORG)76
已完成
2 期
A randomised phase II trial comparing gemcitabine vs TS-1 in patients with resected pancreatic cancerJPRN-UMIN000003544Dokkyo Medical University Hospital60
已完成
2 期
Randomized phase II study of gemcitabine monotherapy versus gemcitabine with an EPA-enriched oral supplement in advanced pancreatic cancer (YCOG001)Pancreatic cancerJPRN-UMIN000003658kanagawa cancer center66
进行中（未招募）
不适用
Prospective randomized Phase II trial with gemcitabine plus sunitinib versus gemcitabine alone in first-line therapy of metastatic or locally advanced pancreatic cancermetastatic or locally advanced pancreatic cancerMedDRA version: 9.1Level: LLTClassification code 10033575Term: Pancreas cancerEUCTR2007-005022-71-DECESAR Central European Society for Anticancer Drug Research – EWIV96